title: Nomogram to predict the benefit from salvage systemic therapy for advanced urothelial carcinoma.
authors.affiliation: UAB Comprehensive Cancer Center, Birmingham, AL, USA.|McMaster University, Hamilton, Ontario, Canada.
authors.forename: Guru
authors.initials: G
authors.lastname: Sonpavde
authors.affiliation: McMaster University, Hamilton, Ontario, Canada.
authors.forename: Gregory R
authors.initials: GR
authors.lastname: Pond
authors.affiliation: Institut de Recherche Pierre Fabre, Boulogne, France.
authors.forename: Ronan
authors.initials: R
authors.lastname: Fougeray
authors.affiliation: Dana-Farber Cancer Institute, Boston, MA, USA.|Harvard Medical School, Boston, MA, USA.|University Hospital del Mar-IMIM, Barcelona, Spain.
authors.forename: Joaquim
authors.initials: J
authors.lastname: Bellmunt
mesh_terms: D002295:Carcinoma, Transitional Cell / Q000175:diagnosis / Q000188:drug therapy*; D006801:Humans; D049451:Nomograms; D011237:Predictive Value of Tests; D016879:Salvage Therapy / Q000379:methods*; D014571:Urologic Neoplasms / Q000175:diagnosis / Q000188:drug therapy*